Helen L. Fitzsimons

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

Michael G. Kaplitt, Andrew Feigin, Chengke Tang et al. · The Lancet · 2007 · 1.1K citations

Medicine, Neurology, Neuroscience +17

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Matthew J. During, Lei Cao, David S. Zuzga et al. · Nature Medicine · 2003 · 844 citations

Life Sciences, Neurobiology, Neuroscience +12

Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model

Jia Luo, Michael G. Kaplitt, Helen L. Fitzsimons et al. · Science · 2002 · 324 citations

Life Sciences, Neurobiology, Neuroscience +17

An Oral Vaccine Against NMDAR1 with Efficacy in Experimental Stroke and Epilepsy

Matthew J. During, C. Wymond Symes, P. Lawlor et al. · Science · 2000 · 221 citations

Life Sciences, Immunology, Neuroscience +17

Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes

Rui‐Hua Xu, C. G. Janson, Mihail Y. Mastakov et al. · Gene Therapy · 2001 · 176 citations

Life Sciences, Molecular Biology, Molecular Genetics +13